Trial Profile
Denosumab in patients with resectable giant cell tumour of bone (GCTB)
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 15 Jul 2015
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Giant cell tumours
- Focus Therapeutic Use
- 15 Jul 2015 New trial record
- 02 Jun 2015 Interim results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.